Quantcast

Latest Alzheimer's disease Stories

2014-05-27 23:06:05

MetLife Foundation has announced the recipients of the 2014 MetLife Foundation Awards for Medical Research: Riqiang Yan, Ph.D., vice chair of the Department of Neurosciences, Lerner Research Institute, Cleveland Clinic; and Lary C. Walker, Ph.D., research professor of neuropharmacology and neurologic diseases and associate professor of neurology, Yerkes National Primate Research Center, Emory University (Atlanta, GA) and Mathias Jucker, Ph.D., full professor, Hertie Institute for Clinical...

2014-05-27 23:02:53

Members of the media are invited to attend and learn more about the three-year Alzheimer Society of Toronto project. Toronto, ON (PRWEB) May 27, 2014 The first year results of the Music and Memory: iPod Project by the Alzheimer Society of Toronto, that provides free iPod shuffles to people with Alzheimer’s disease and other dementias and to their caregivers, will be announced on May 29. Paul Williams of Balance of Care Research and Evaluation Group examined the first year of the...

2014-05-27 08:29:52

ALISO VIEJO, Calif., May 27, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced completion of patient enrollment in the company's phase II, placebo controlled study testing AVP-923 for the treatment of agitation in Alzheimer's disease patients. Top-line results from this study are expected late September/early October. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO "Final completion of enrollment in this study is an important milestone for...

2014-05-27 08:28:32

BEVERLY HILLS, Calif., May 27, 2014 /PRNewswire/ -- ImmunoClin Corporation (OTCBB: IMCL), is a U.S. healthcare company specializing in personalized medicine, developing strategies to fight inflammatory conditions that are the underlying cause of pathologies in multiple conditions affecting the majority of human population: infections, cancer, cardiovascular disease, and dementia, including Alzheimer's disease. ImmunoClin is pleased to appoint Professor Antony Bayer as a member of...

2014-05-26 13:27:58

Canadian Association for Neuroscience Mechanism uncovered could also help preserve neuron function in Alzheimer's disease, traumatic brain injury and other neurodegenerative conditions Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease. As Huntington...

2014-05-23 12:24:34

WASHINGTON, May 23, 2014 /PRNewswire-USNewswire/ -- In March of this year, a team of Georgetown University scientists published research showing that, for the first time ever, a blood test has the potential to predict Alzheimer's disease before patients start showing symptoms. AACC is pleased to announce that a late-breaking session at the 2014 AACC Annual Meeting & Clinical Lab Expo in Chicago will expand upon this groundbreaking research and discuss why it could be the key to...

2014-05-23 08:24:08

BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc. a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase III clinical study submitted in its IND application. This study is for its lead program, ALZT-OP1, a novel combination therapy for the prevention and treatment of early Alzheimer's disease. ALZT-OP1 is a...

2014-05-22 08:31:13

--Research Includes Stem Cells, Imaging and Exercise for Cognition-- MIAMI, May 22, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced today that it has funded four new grants in Parkinson's disease (PD) research. The four grants target key scientific questions about how Parkinson's develops and how to optimize treatment. "NPF is propelling the most potentially transformative research forward," said Joyce Oberdorf, NPF's President and CEO. "This...

2014-05-21 23:12:59

On the summer solstice, June 21, volunteer teams raise funds and awareness for the Alzheimer's Association from sunrise to sunset in recognition of caregivers, for whom every day is the longest day. Denver, CO (PRWEB) May 21, 2014 People across Colorado and around the world will join together to honor those facing Alzheimer's disease by participating in The Longest Day® on Saturday, June 21, 2014. The Longest Day is a sunrise-to-sunset team fundraising event to honor the...

2014-05-21 16:27:02

PITTSBURGH, May 21, 2014 /PRNewswire/ -- Cognition Therapeutics Inc. (CogRx), an innovative research and drug discovery organization focused on the development of novel disease-modifying therapeutics for neurodegenerative diseases, announced today that its small molecule soluble Abeta receptor antagonist program for the treatment of Alzheimer's disease (AD) has been selected for funding by the National Institute on Aging (NIA)/NIH Alzheimer's Disease Drug Development Program (U01)....


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.